Filing Details
- Accession Number:
- 0000950138-10-000173
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-15 13:00:00
- Reporting Period:
- 2010-03-11
- Filing Date:
- 2010-03-15
- Accepted Time:
- 2010-03-15 18:40:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1289340 | Stereotaxis Inc. | STXS | Electromedical & Electrotherapeutic Apparatus (3845) | 943120386 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1299102 | J Bevil Hogg | C/O Stereotaxis Inc. 4320 Forest Park Ave., Suite 100 St. Louis MO 63108 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-03-11 | 55,555 | $1.62 | 336,437 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-12 | 32,000 | $5.53 | 304,437 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-03-11 | 55,555 | $0.00 | 55,555 | $1.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,333 | 2001-11-08 | 2010-12-31 | No | 4 | M | Direct |
Footnotes
- Sold to cover exercise price and tax withholding obligations in connection with exercise of options.
- The reported price is the weighted average sales price per share for multiple transactions in which the sales prices ranged from $5.52 to $5.58 per share. The reporting person undertakes to provide full information regarding the number of shares sold at each separate sales price upon request of the Securities and Exchange Commission staff, the issuer or any security holder of the issuer.
- Price not applicable to acquisitions resulting from grants of stock options.
Billionaire Hedge Funds
